{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:24:46Z","timestamp":1788229486592,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T00:00:00Z","timestamp":1482710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5T32AI100851-03"],"award-info":[{"award-number":["5T32AI100851-03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We report 2 cases of disseminated cryptococcosis with central nervous system involvement in patients with chronic lymphoid malignancies occurring within 1 month of starting on ibrutinib. Characteristically, in both cases, no inflammation was seen in the cerebrospinal fluid. Central nervous system mycoses should be considered as a potential complication of ibrutinib.<\/jats:p>","DOI":"10.1093\/ofid\/ofw261","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T01:30:42Z","timestamp":1482802242000},"source":"Crossref","is-referenced-by-count":50,"title":["Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib"],"prefix":"10.1093","volume":"4","author":[{"given":"Julia A.","family":"Messina","sequence":"first","affiliation":[{"name":"Department of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen K.","family":"Maziarz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Spec","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Washington University, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Perfect","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,9]]},"reference":[{"key":"2020081004563590700_CIT0001","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.amjmed.2011.10.010","article-title":"The impact of the host on fungal infections","volume":"125","author":"Perfect","year":"2012","journal-title":"Am J Med"},{"key":"2020081004563590700_CIT0002","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1086\/320524","article-title":"Cryptococcosis in patients with cancer","volume":"32","author":"Kontoyiannis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020081004563590700_CIT0003","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/10428194.2012.717081","article-title":"Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia","volume":"54","author":"Marchand","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2020081004563590700_CIT0004","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N Engl J Med"},{"key":"2020081004563590700_CIT0005","volume-title":"IMBRUVICA\u00ae","year":"2016"},{"key":"2020081004563590700_CIT0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"key":"2020081004563590700_CIT0007","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood-2015-03-635326","article-title":"Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"2020081004563590700_CIT0008","volume-title":"LEVAQUIN\u00ae","year":"2008"},{"key":"2020081004563590700_CIT0009","volume-title":"AmBisome\u00ae","year":"2012"},{"key":"2020081004563590700_CIT0010","volume-title":"ANCOBON\u00ae","year":"2013"},{"key":"2020081004563590700_CIT0011","volume-title":"DIFLUCAN\u00ae","year":"2011"},{"key":"2020081004563590700_CIT0012","volume-title":"Cryptococcal Antigen Lateral Flow Assay","year":"2016"},{"key":"2020081004563590700_CIT0013","first-page":"1593","article-title":"Ibrutinib for chronic lymphocytic leukemia","volume":"374","author":"Ruchlemer","year":"2016","journal-title":"N Engl J Med"},{"key":"2020081004563590700_CIT0014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00005792-198303000-00003","article-title":"Cryptococcemia","volume":"62","author":"Perfect","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"2020081004563590700_CIT0015","first-page":"4642831","article-title":"Disseminated cryptococcal disease in a patient with chronic lymphocytic leukemia on ibrutinib","volume":"2016","author":"Okamoto","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"2020081004563590700_CIT0016","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2015.06.031","article-title":"Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: molecular, immunologic, and clinical heterogeneity","volume":"136","author":"Perez de Diego","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2020081004563590700_CIT0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cmi.2011.58","article-title":"C-type lectin receptor-induced NF-\u03baB activation in innate immune and inflammatory responses","volume":"9","author":"Kingeter","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"2020081004563590700_CIT0018","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaci.2014.06.015","article-title":"The CARD11-BCL10-MALT1 (CBM) signalosome complex: stepping into the limelight of human primary immunodeficiency","volume":"134","author":"Turvey","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2020081004563590700_CIT0019","doi-asserted-by":"crossref","first-page":"e1005293","DOI":"10.1371\/journal.ppat.1005293","article-title":"CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system","volume":"11","author":"Drummond","year":"2015","journal-title":"PLoS Pathog"},{"key":"2020081004563590700_CIT0020","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2012-08-450551","article-title":"Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency","volume":"121","author":"Drewniak","year":"2013","journal-title":"Blood"},{"key":"2020081004563590700_CIT0021","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/160.5.912","article-title":"Cryptococcal meningitis with normal cerebrospinal fluid","volume":"160","author":"Shaunak","year":"1989","journal-title":"J Infect Dis"},{"key":"2020081004563590700_CIT0022","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/clinids\/23.2.369","article-title":"Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus","volume":"23","author":"Darras-Joly","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020081004563590700_CIT0023","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S0036-46651997000600003","article-title":"Cerebrospinal fluid profiles in acquired immunodeficiency syndrome with and without neurocryptococcosis","volume":"39","author":"Garlipp","year":"1997","journal-title":"Rev Inst Med Trop Sao Paulo"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/1\/ofw261\/33622564\/ofw261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/1\/ofw261\/33622564\/ofw261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T08:56:57Z","timestamp":1597049817000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofw261\/2740624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofw261","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017]]},"published":{"date-parts":[[2017,1,1]]},"article-number":"ofw261"}}